Abstract
NO is a key signaling molecule that has a wide range of biological functions including vasodilation and neurotransmission, and is implicated in several pathological conditions. Therefore, modulation of NO is a desired step in curbing the NO-associated disease processes. Targetting NOS proteins and inhibiting their activity to reduce NO production is a major approach since the inception of NOS inhibitor research. Although a series of NOS inhibitors have been developed, synthesized and practiced in experimental biology, no NOS inhibitor has been approved as yet a drug for therapeutic uses. The present review elaborates the scope of the clinical uses of NOS inhibitors and the inherent limitations of the process that makes the approach less successful so far in clinic.
Keywords: Nitric Oxide (NO), Nitric Oxide Synthase (NOS), Nitric Oxide Synthase inhibitors, NOS oxidase domain, NOS reductase domain.
Current Enzyme Inhibition
Title:Inhibitors of Nitric Oxide Synthase: What's up and What's Next?
Volume: 12 Issue: 1
Author(s): Lakshmikirupa Sundaresan, Suvendu Giri and Suvro Chatterjee
Affiliation:
Keywords: Nitric Oxide (NO), Nitric Oxide Synthase (NOS), Nitric Oxide Synthase inhibitors, NOS oxidase domain, NOS reductase domain.
Abstract: NO is a key signaling molecule that has a wide range of biological functions including vasodilation and neurotransmission, and is implicated in several pathological conditions. Therefore, modulation of NO is a desired step in curbing the NO-associated disease processes. Targetting NOS proteins and inhibiting their activity to reduce NO production is a major approach since the inception of NOS inhibitor research. Although a series of NOS inhibitors have been developed, synthesized and practiced in experimental biology, no NOS inhibitor has been approved as yet a drug for therapeutic uses. The present review elaborates the scope of the clinical uses of NOS inhibitors and the inherent limitations of the process that makes the approach less successful so far in clinic.
Export Options
About this article
Cite this article as:
Sundaresan Lakshmikirupa, Giri Suvendu and Chatterjee Suvro, Inhibitors of Nitric Oxide Synthase: What's up and What's Next?, Current Enzyme Inhibition 2016; 12 (1) . https://dx.doi.org/10.2174/1573408012666151126185922
DOI https://dx.doi.org/10.2174/1573408012666151126185922 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cyclodextrin Based Nanosponges: A Multidimensional Drug Delivery System and its Biomedical Applications
Current Drug Delivery Perspectives on Brain-Targeting Drug Delivery Systems
Current Pharmaceutical Biotechnology Clinical Characteristics and Treatment of Cardiomyopathies in Children
Current Cardiology Reviews Stent-Based Delivered Anti-Proliferative Drugs in the Prevention of Coronary Stent Restenosis
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Why and How We Should Treat Elderly Patients with Hypertension?
Current Vascular Pharmacology Scleroderma Renal Crisis Accompanied by New-Onset Pulmonary Hypertension: An Acute Systemic Endothelial Injury? Case Report and Literature Review
Inflammation & Allergy - Drug Targets (Discontinued) Ventilatory Support in Persistent Pulmonary Hypertension of the Newborn
Current Respiratory Medicine Reviews Renin-Angiotensin-Aldosterone System in Autosomal Dominant Polycystic Kidney Disease
Current Hypertension Reviews Putative Role for Apelin in Pressure/Volume Homeostasis and Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Immunotoxins in the Treatment of Hematologic Malignancies
Current Drug Targets Nursing Assessment, Education, and Care of Extremely Premature Neonates with Patent Ductus Arteriosus
Current Pediatric Reviews A Closer Look at α-Secretase
Current Alzheimer Research Production Technology and Functionality of Bioactive Peptides
Current Pharmaceutical Design Microbial Efflux Pump Inhibition: Tactics and Strategies
Current Pharmaceutical Design A Concise and Useful Guide to Understand How Alpha<sub>1</sub> Adrenoceptor Antagonists Work
Mini-Reviews in Medicinal Chemistry Adverse Drug Reactions: Trends in a Tertiary Care Hospital
Current Drug Safety Clinical Pharmacology of Systemic Analgesics in Neonates
Current Drug Therapy Ghrelin and Cardiovascular Diseases
Current Cardiology Reviews Postural Orthostatic Tachycardia Syndrome and Orthostatic Hypotension Post COVID-19
Infectious Disorders - Drug Targets Cardiotonic Steroids in Adaptation to Dietary Salt Intake
Current Clinical Pharmacology